Farther Finance Advisors LLC grew its stake in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 788.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 968 shares of the company’s stock after acquiring an additional 859 shares during the quarter. Farther Finance Advisors LLC’s holdings in Azenta were worth $33,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in the stock. GAMMA Investing LLC lifted its holdings in shares of Azenta by 4,054.6% during the first quarter. GAMMA Investing LLC now owns 65,019 shares of the company’s stock valued at $2,252,000 after purchasing an additional 63,454 shares in the last quarter. Alpha Wealth Funds LLC bought a new position in shares of Azenta during the fourth quarter valued at $225,000. Alpine Global Management LLC bought a new position in shares of Azenta during the fourth quarter valued at $218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Azenta by 6.2% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 170,845 shares of the company’s stock valued at $8,542,000 after purchasing an additional 9,969 shares in the last quarter. Finally, Squarepoint Ops LLC lifted its holdings in shares of Azenta by 68.9% during the fourth quarter. Squarepoint Ops LLC now owns 171,318 shares of the company’s stock valued at $8,566,000 after purchasing an additional 69,869 shares in the last quarter. 99.08% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on AZTA. Needham & Company LLC lowered their price target on Azenta from $59.00 to $40.00 and set a “buy” rating on the stock in a report on Wednesday, May 7th. TD Cowen upgraded Azenta to a “hold” rating in a research report on Thursday, February 27th.
Azenta Stock Performance
Azenta stock opened at $30.11 on Wednesday. The stock has a market cap of $1.38 billion, a PE ratio of -21.66 and a beta of 1.62. Azenta, Inc. has a one year low of $23.91 and a one year high of $63.58. The stock has a fifty day moving average of $27.65 and a 200 day moving average of $38.51.
Azenta (NASDAQ:AZTA – Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). Azenta had a positive return on equity of 1.30% and a negative net margin of 10.31%. During the same period in the previous year, the firm posted $0.06 earnings per share. Azenta’s quarterly revenue was up 5.1% compared to the same quarter last year. As a group, sell-side analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Further Reading
- Five stocks we like better than Azenta
- Profitably Trade Stocks at 52-Week Highs
- 3 Hot Trades for Insiders, But Are They Good Buys for Investors?
- Investing In Automotive Stocks
- Why Qualcomm’s Latest Price Target Can’t Be Ignored
- What Are Dividend Champions? How to Invest in the Champions
- Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.